-transparent.png){kind=logo}
The in-vitro activity of ofloxacin was evaluated against recently isolated Chlamydia trachomatis strains from patients suffering from non-gonococcal urethritis. The minimal inhibitory concentration (MIC) proved to be 1 mg/l against 8 of the 10 strains assayed (the MICs for the other two strains were 0.5 and 2 mg/l). The data obtained confirm that ofloxacin is active against Chlamydia trachomatis at concentrations achievable with the routine dosage regimen. The drug may thus be regarded as potentially useful for the treatment of non-gonococcal urethritis due to Chlamydia.
Related Publications
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
December 1989,
The American journal of medicine,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
January 1987,
Drugs,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
January 1990,
The Journal of antimicrobial chemotherapy,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
December 1980,
Antimicrobial agents and chemotherapy,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
October 1988,
The Journal of antimicrobial chemotherapy,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
June 1983,
European journal of clinical microbiology,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
July 1979,
The Journal of antimicrobial chemotherapy,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
January 1981,
Sexually transmitted diseases,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
September 1994,
Antimicrobial agents and chemotherapy,
V Sambri, and
F Rumpianesi, and
L Xerri, and
R Cevenini
February 1998,
Pathologie-biologie,
